Biotechnology Allogene Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference January 4, 2023
Biotechnology Online Enrollment Now Open for Physicians Requesting Expanded Access to Ascendis Pharma’s TransCon(TM) PTH for Eligible U.S. Adult Patients with Hypoparathyroidism January 4, 2023
Biotechnology Editas Medicine to Present at the 41st Annual J.P. Morgan Healthcare Conference January 4, 2023
Biotechnology Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer January 3, 2023
Biotechnology European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2 January 3, 2023
Biotechnology Fate Therapeutics (FATE) Loses -50.54% in 4 Weeks, Here’s Why a Trend Reversal May be Around the Corner January 3, 2023
Biotechnology Halozyme to Present at the 41st Annual J.P. Morgan Healthcare Conference January 3, 2023
Biotechnology Allogene Appoints Zachary J. Roberts, M.D., Ph.D. as Executive Vice President of Research & Development January 3, 2023
Search
